Von Hippel-Lindau disease

Russell R. Lonser, Gladys M. Glenn, McClellan Walther, Emily Y. Chew, Steven K. Libutti, W. Marston Linehan, Edward H. Oldfield

Research output: Contribution to journalArticle

871 Citations (Scopus)

Abstract

von Hippel-Lindau disease is a heritable multisystem cancer syndrome that is associated with a germline mutation of the VHL tumour suppressor gene on the short arm of chromosome 3. This disorder is not rare (about one in 36 000 livebirths) and is inherited as a highly penetrant autosomal dominant trait (ie, with a high individual risk of disease). Affected individuals are at risk of developing various benign and malignant tumours of the central nervous system, kidneys, adrenal glands, pancreas, and reproductive adnexal organs. Because of the complexities associated with management of the various types of tumours in this disease, treatment is multidisciplinary. We present an overview of the clinical aspects, management, and treatment options for von Hippel-Lindau disease.

Original languageEnglish (US)
Pages (from-to)2059-2067
Number of pages9
JournalLancet
Volume361
Issue number9374
DOIs
StatePublished - Jun 14 2003
Externally publishedYes

Fingerprint

von Hippel-Lindau Disease
Central Nervous System Neoplasms
Chromosomes, Human, Pair 3
Germ-Line Mutation
Adrenal Glands
Tumor Suppressor Genes
Pancreas
Neoplasms
Kidney
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lonser, R. R., Glenn, G. M., Walther, M., Chew, E. Y., Libutti, S. K., Linehan, W. M., & Oldfield, E. H. (2003). Von Hippel-Lindau disease. Lancet, 361(9374), 2059-2067. https://doi.org/10.1016/S0140-6736(03)13643-4

Von Hippel-Lindau disease. / Lonser, Russell R.; Glenn, Gladys M.; Walther, McClellan; Chew, Emily Y.; Libutti, Steven K.; Linehan, W. Marston; Oldfield, Edward H.

In: Lancet, Vol. 361, No. 9374, 14.06.2003, p. 2059-2067.

Research output: Contribution to journalArticle

Lonser, RR, Glenn, GM, Walther, M, Chew, EY, Libutti, SK, Linehan, WM & Oldfield, EH 2003, 'Von Hippel-Lindau disease', Lancet, vol. 361, no. 9374, pp. 2059-2067. https://doi.org/10.1016/S0140-6736(03)13643-4
Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM et al. Von Hippel-Lindau disease. Lancet. 2003 Jun 14;361(9374):2059-2067. https://doi.org/10.1016/S0140-6736(03)13643-4
Lonser, Russell R. ; Glenn, Gladys M. ; Walther, McClellan ; Chew, Emily Y. ; Libutti, Steven K. ; Linehan, W. Marston ; Oldfield, Edward H. / Von Hippel-Lindau disease. In: Lancet. 2003 ; Vol. 361, No. 9374. pp. 2059-2067.
@article{cde3bbe67fc24d619608ae08f7bd8e0f,
title = "Von Hippel-Lindau disease",
abstract = "von Hippel-Lindau disease is a heritable multisystem cancer syndrome that is associated with a germline mutation of the VHL tumour suppressor gene on the short arm of chromosome 3. This disorder is not rare (about one in 36 000 livebirths) and is inherited as a highly penetrant autosomal dominant trait (ie, with a high individual risk of disease). Affected individuals are at risk of developing various benign and malignant tumours of the central nervous system, kidneys, adrenal glands, pancreas, and reproductive adnexal organs. Because of the complexities associated with management of the various types of tumours in this disease, treatment is multidisciplinary. We present an overview of the clinical aspects, management, and treatment options for von Hippel-Lindau disease.",
author = "Lonser, {Russell R.} and Glenn, {Gladys M.} and McClellan Walther and Chew, {Emily Y.} and Libutti, {Steven K.} and Linehan, {W. Marston} and Oldfield, {Edward H.}",
year = "2003",
month = "6",
day = "14",
doi = "10.1016/S0140-6736(03)13643-4",
language = "English (US)",
volume = "361",
pages = "2059--2067",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9374",

}

TY - JOUR

T1 - Von Hippel-Lindau disease

AU - Lonser, Russell R.

AU - Glenn, Gladys M.

AU - Walther, McClellan

AU - Chew, Emily Y.

AU - Libutti, Steven K.

AU - Linehan, W. Marston

AU - Oldfield, Edward H.

PY - 2003/6/14

Y1 - 2003/6/14

N2 - von Hippel-Lindau disease is a heritable multisystem cancer syndrome that is associated with a germline mutation of the VHL tumour suppressor gene on the short arm of chromosome 3. This disorder is not rare (about one in 36 000 livebirths) and is inherited as a highly penetrant autosomal dominant trait (ie, with a high individual risk of disease). Affected individuals are at risk of developing various benign and malignant tumours of the central nervous system, kidneys, adrenal glands, pancreas, and reproductive adnexal organs. Because of the complexities associated with management of the various types of tumours in this disease, treatment is multidisciplinary. We present an overview of the clinical aspects, management, and treatment options for von Hippel-Lindau disease.

AB - von Hippel-Lindau disease is a heritable multisystem cancer syndrome that is associated with a germline mutation of the VHL tumour suppressor gene on the short arm of chromosome 3. This disorder is not rare (about one in 36 000 livebirths) and is inherited as a highly penetrant autosomal dominant trait (ie, with a high individual risk of disease). Affected individuals are at risk of developing various benign and malignant tumours of the central nervous system, kidneys, adrenal glands, pancreas, and reproductive adnexal organs. Because of the complexities associated with management of the various types of tumours in this disease, treatment is multidisciplinary. We present an overview of the clinical aspects, management, and treatment options for von Hippel-Lindau disease.

UR - http://www.scopus.com/inward/record.url?scp=0037709883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037709883&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(03)13643-4

DO - 10.1016/S0140-6736(03)13643-4

M3 - Article

VL - 361

SP - 2059

EP - 2067

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9374

ER -